Article
Spatial remodeling of the urothelial carcinoma tumor microenvironment shapes response to neoadjuvant atezolizumab
2026-04-20
Abstract excerpt
<h4>ABSTRACT</h4> The ABACUS study was a single arm, phase II trial evaluating neoadjuvant atezolizumab in operable urothelial carcinoma. Initial bulk transcriptomic and immunohistochemistry analyses suggested links between immune activation, tissue remodeling, and resistance pathways such as transforming growth factor β that were associated with clinical outcome. To further characterize spatial and phenotypic ch...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 13a7bb90-8dfd-528a-a34d-9f21cd09a3b1
- DOI
- 10.64898/2026.04.15.26350980
